跳至主要内容
临床试验/NCT03754816
NCT03754816已完成不适用

The Combination of PECS II Block and Parasternal Block Provide Useful Analgesia After Radical Mastectomy With Axillary Dissection and Implant Breast Reconstruction

San Salvatore Hospital of L'Aquila1 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2018年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
65
试验地点
1
主要终点
Postoperative pain: Numeric Rate Scale

研究概览

简要总结

The combination of PECS II and parasternal Block provides analgesia after radical mastectomy

详细描述

The cambionation of PECS II block and parasternal block

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • ASA status patients:1,2 and 3
  • patients undergoing to radical mastectomy with axillary dissection and breast-implant reconstruction

排除标准

  • patients with allergy to local anesthetics
  • ASA status patients: 4
  • breast anatomy abnormalities
  • neurological diseases
  • septic conditions
  • coagulopathies
  • drug abuse history

研究组 & 干预措施

Experimental group

Experimental

The combination of PECS II and parasternal block performed by injecting Levobupivacaine 0.375% 40 ml, injected between minor and major pectoralis muscles, between minor and serratus muscles and between major and intercostal muscles

干预措施: PECS II and parasternal block (Procedure)

Experimental group

Experimental

The combination of PECS II and parasternal block performed by injecting Levobupivacaine 0.375% 40 ml, injected between minor and major pectoralis muscles, between minor and serratus muscles and between major and intercostal muscles

干预措施: Levobupivacaine (Drug)

结局指标

主要结局

Postoperative pain: Numeric Rate Scale

时间窗: 24 hours after surgery

Postoperative pain evaluated with Numeric Rate Scale, from 0 (no pain) to 10 (worst pain)

次要结局

  • Intraoperative opiates(From start to the end of surgery)
  • Side effects(24 hours after surgery)
  • Postoperative opiates(24 hours after surgery)

研究者

发起方
San Salvatore Hospital of L'Aquila
申办方类型
Other
责任方
Principal Investigator
主要研究者

Emiliano Petrucci

Principal Investigator

San Salvatore Hospital of L'Aquila

研究点 (1)

Loading locations...

相似试验